-

Kirby McInerney LLP Urges Investors in TELUS International (Cda) Inc. (TIXT) to Inquire About Their Rights in Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired TELUS International (Cda) Inc. (“TELUS” or the “Company”) (NYSE:TIXT) securities during the period from February 16, 2024, through August 1, 2024 (“the Class Period”). Investors have until March 31, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

[LEARN MORE ABOUT THE CLASS ACTION]

On May 9, 2024, before the market opened, TELUS released its Q1 2024 financial results. The release revealed that TELUS was experiencing declining revenue, including a $29 million decrease in revenue year-over-year. On the same day, in the associated earnings call, CEO Gopi Chande was asked by an analyst to clarify “what margin should look like on a go-forward basis” as margins “were down year-over-year and were below the full year guidance.” Chande answered that the margins generated by the Company’s AI offerings “can be a bit below average.” On this news, the price of TELUS shares declined by $1.41 per share, or approximately 18.15%, from $7.77 per share on May 8, 2024, to close at $6.36 on May 9, 2024.

On August 2, 2024, before the market opened, TELUS released its Q2 2024 financial results. TELUS reported revenues of $652 million, a decrease of $15 million or 2% year-over-year, which the Company attributed to lower revenues from a leading social media client and other technology clients. TELUS also reported a $23 million or 15% quarter-over-quarter adjusted EBITDA decrease and a 14.6% quarter-over-quarter reduction in adjusted EBITDA margin, from 23.3% to 19.9%. TELUS also disclosed that Jeff Puritt, then-President and CEO, was set to retire effective September 3, 2024. On an associated earnings call held the same day, Puritt disclosed the transition of the Company “towards a more technology centric and specifically AI fueled business,” “necessitates some cannibalization of our tenured and higher margin CX work.” Puritt further revealed that the Company’s AI offerings had put TELUS in the “unendurable position” of allowing the “complete eradication of margin yields in order to enjoy the revenue upside” of AI. Puritt concluded that, ultimately, the Company is “going to have to take it on the chin a little bit in terms of our historical margin profile.” On this news, the price of TELUS shares declined by $2.33 per share, or approximately 36%, from $6.48 per share on August 1, 2024, to close at $4.15 on August 2, 2024.

The complaint alleges that defendants, throughout the Class Period, failed to disclose to investors: (1) the Company’s AI Data Solutions offerings required the cannibalization of its higher-margin offerings; (2) that TELUS’ declining profitability was tied to the Company’s drive to develop AI capabilities; and (3) that TELUS’ shift toward AI put greater pressure on the Company’s margins than previously disclosed.

If you purchased or otherwise acquired TELUS securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the form below, to discuss your rights or interests with respect to these matters without any cost to you.

[CONTACT FORM]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NYSE:TIXT

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

ADMA BIOLOGICS, INC. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ:ADMA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 24, 2026, Culper Research published a report on ADMA alleging “Channel Stuffing, an Undisclos...

IBRX ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of ImmunityBio, Inc. Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) securities during the period of January 19, 2026 through March 24, 2026, inclusive (“the Class Period”). If you suffered a loss on your ImmunityBio investments, you have until May 26, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERE...

PYPL DEADLINE NOTICE: PayPal Holdings, Inc. Investors Encouraged to Contact Kirby McInerney LLP By April 20, 2026

NEW YORK--(BUSINESS WIRE)--If you suffered a loss on your investment inPayPal Holdings, Inc. (“PayPal” or the “Company”) (NASDAQ:PYPL), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until April 20, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaintiff ove...
Back to Newsroom